Novo Nordisk continues its journey, which began with the life-saving discovery of insulin, by enhancing the quality of life for individuals with diabetes through innovative digital treatment methods.
Thanks to the new technologies introduced by Novo Nordisk in diabetes treatment, patients can automatically record and track their insulin doses and application times.
Ömer Buğra Bahadır, MD, Senior Director of Clinical, Medical, and Regulatory at Novo Nordisk Turkey, emphasized that diabetes continues to increase rapidly in Turkey and globally. According to current data published by the International Diabetes Federation (IDF), there are approximately 9 million diabetes patients in Turkey, and it is projected to reach 13 million by 2045.
Bahadır highlighted the importance of innovative treatments in facilitating the adherence of diabetic patients to treatment: “The daily management of diabetes poses a substantial burden for patients. Diabetic individuals spend an average of one hour a day on treatment management and can only achieve normal blood sugar levels for half of the day. With the new technologies introduced by Novo Nordisk in diabetes treatment, patients can automatically record their insulin doses and adjust the dose amount and timing. This technology enables the storage of patient data in the memory of their mobile devices, offering healthcare professionals more frequent monitoring capabilities. As a result, the patient’s treatment adherence will increase, making it easier to achieve treatment goals.”
